A082002: A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or without SBRT for PD-L1-Negative, Advanced Non-small Cell Lung Cancer
Details
Age
Adult
Eligibility
Stage IV NSCLC, PD-L1 expression Tumor Proportion Score < 1%, ECOG 0-2, No prior systemic chemotherapy or immunotherapy for advanced NSCLC, no prior treatment with checkpoint inhibitors for metastatic lung cancer
Type of Study
Treatment
Locations
Greeley Campus
Harmony Campus
Medical Center of the Rockies
Memorial Hospital Central
Memorial Hospital North
Poudre Valley Hospital
Principal Investigator
Steven Schuster, MD
Study ID
Protocol Number: 22-1109
More information available at ClinicalTrials.gov: NCT04929041
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers